close
Add to watchlist
Intuitive Surgical Inc (ISRG) Healthcare, Medical Equipment & Supplies
Intuitive Surgical, Inc., together with its subsidiaries, engages in the design, manufacture, and marketing of da Vinci surgical systems for use in urologic, gynecologic, cardiothoracic, and general surgeries. Its surgical systems consist of a surgeon's console, a patient-side cart, a vision system, and wristed instruments and surgical accessories. The da Vinci surgical system controls intuitive surgical endoscopic instruments, including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pickups, needle holders, endoscopic retractors, electrocautery, ultrasonic cutters, and accessories during a range of surgical procedures. Its surgical systems translate the surgeon's natural hand movements on instrument controls at the console into corresponding micro-movements of instruments positioned inside the patient through small puncture incisions or ports, as well as provides the surgeon with the intuitive control, range of motion, fine tissue manipulation capability, and 3-D vision characteristic of open surgery, while simultaneously allowing the surgeon to work through the small ports of MIS. The company also manufactures various EndoWrist instruments, including forceps, scissors, electrocautery, scalpels, and other surgical tools. In addition, it sells various accessory products, including sterile drapes used to protect the sterile field during surgery; and vision products, such as replacement 3-D stereo endoscopes, camera heads, and light guides. Intuitive Surgical, Inc. sells its products through sales representatives and distributors in North America, South America, Europe, the Middle East, Australia, and Asia. The company was founded in 1995 and is headquartered in Sunnyvale, California.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 528.20 |
| Volume | 252963 |
| Volume Avg | 347076 |
| 52 Week High | 531.98 |
| 52 Week Low | 315.01 |
| PE | 43.13 |
| PE (group average) | 39 |
| EPS Year | 12.32 |
| EPS change Q/Q | -14.19% |
| EPS change Q/Q Yr ago | 20.91% |
| EPS change Q/Q next Q est | -24.22% |
| EPS change Y/Y | -26.03% |
| REV change Q/Q | -0.31% |
| REV change Q/Q Yr ago | 18.11% |
| EPS next Q est | 3.51 |
| EPS next Y est | 16.94 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |